Sarcoidosis;Sarcoidose

Annales de Dermatologie et de Venereologie

Volumn 124, Issue 1, 1997, Pages 102-111

  Sassolas, B ^a   Castanet, J ^b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOSTIMULATING AGENT; IMMUNOSUPPRESSIVE AGENT; ISOTRETINOIN; MELATONIN; METHOTREXATE; OXYPHENBUTAZONE; PLACEBO; PREDNISONE; THALIDOMIDE; TRANILAST; ANTIMALARIAL AGENT;

CLINICAL TRIAL; HUMAN; LASER SURGERY; PUVA; REVIEW; SARCOIDOSIS; FEMALE; MALE; PREGNANCY; PREGNANCY COMPLICATION; PROGNOSIS; SKIN DISEASE;

ADRENAL CORTEX HORMONES; ANTIMALARIALS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; SARCOIDOSIS; SKIN DISEASES;

EID: 0031046403     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Russo G, Millikan LE. Cutaneous sarcoidosis: diagnosis and treatment.. Compreh Therapy 1994;20(7):418-421.
2. Crickx B. Bilan d'une sarcoïdose cutanée. Ann. Dermatol. Venereol. 1992;119:581-582.
3. Callen JP, Mahl CF. Oculocutaneous manifestations observed in multisystem disorders. Dermatol Clinics 1992;10:709-716.
4. James DG. Sarcoidosis; Definition and classification. Lung biology in health and disease 1994;73:19-43.
5. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agenls. Chest. 1989;95: (Suppl)2-4.
6. Poynard T. Evaluation de la qualité méthodologique des essais thérapeutiques randomisés Presse Med. 1988;17:315-318.
7. Du Bois RM. Corticosteroids in sarcoidosis: friend or foe ? Eur. Respir. J. 1994;7:1203-09.
8. Selroos OBN. Biochemical markers in sarcoidosis. Critical Review in Clinical Laboratory Sciences 1986;24:185-216.
9. Sharma OP. Pulmonary sarcoidosis and corticostcroids. Am Rev Respir Dis 1993;147:1598-1600.
10. Khatri KA, Chotzen VA, Burrall BA. Lupus Pernio: successful treatment with a potent topical corticosteroid. Arch Dermatol 1995;131:617-618
11. Gupta AK, Goldfarb MT, Rasmussen JE. Papular midfacial eruption in a child. Arch Dermatol 1989;125:1704-1705,1707-1708.
12. Muthiah MM, MacFarlane JT. Current concepts in the management of sarcoidosis. Drugs 1990;40:231-237.
13. Eule H, Weinecke A, Roth I, Wuthe H. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study. Ann. NY Acad Sci 1986;465:695-701.
14. Izumi T. Are Corticosteroids harmful to sarcoidosis? Sarcoidosis 1994;11 (Suppl. 1): 119-22.
15. Samtsov AV. Cutaneous sarcoidosis. Int J Dermatol 1992; 31: 385-391.
16. De Remee R.A. Sarcoidosis. Mayo Clin. Proc. 1995; 70:177-181.
17. Spiteri MA, Matthey F, Gordon T, Carstairs LS, James DG. Lupus pernio: a clinico-radiological study of thirty-five cases. Br J Dermatol. 1985;112:315-322.
18. Zaki MH, Lyons HA, Leilop L, Huang CT. Corticosteroid therapy in sarcoidosis. NY State J Med 1987;87:497-499.
19. Yamamoto M, Saito N, Tachibana. Effect of 18-month corticosteroid therapy on the stage I and stage II sarcoidosis patients. Ann. NY Acad Sci. 1976;278:7220-8.
20. Harkleroad LE, Young RL, Savage PJ, Jenkins DN, London RE. Pulmonary sarcoïdosis, long term follow-up of the effects of steroid therapy. Chest 1982;8:84-7.
21. James DG. Sarcoidosis; Treatment. Lung Biology in health and disease 1994;75:607-617.
22. Johns CJ, Mac Gregor MI, Zachary JB, Ball WC. Extended experience in the long term corticosteroid treatment of pulmonary sarcoidosis. Ann. NY Acad Sci 1976;278:722-31.
23. Hunninghake GW, Gilbert S. Pueringer R, Dayton C, Floerchinger C, Helmers R, Merchant R, Wilson J, Galvin J, Schwartz D. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994;149:893-8.
24. Baughman RP, Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 1990;142:1268-1271.
25. Zic JA. Horowitz DH, Arzubiaga C, King LE. Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. Arch Dermatol 1991;127:1034-1040.
26. Ribrioux A. Antipaludéens de synthèse et peau. Ann Dermatol Vénéréol 1990;117:975-90.
27. Morse SI, Cohn ZA, Hirsch JG, Shaedler RW. The treatment of sarcoidosis with chloroquine. Am J Med 1961;30:779-784.
28. Hirsh JG. Experimental treatment with chloroquine. Am Rev Respir Dis 1961;84:52-58.
29. Davies D. Sarcoidosis treated by chloroquine. Br J Dis Chest 1963;57:30-36.
30. Siltzbach LE, Terstein AS. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand 1964; 176 (suppl 425):302-308.
31. Morse SI. The therapeutic effect of chloroquine in sarcoidosis. In: Turiaf J, Chabot J, eds. La sarcoïdose: rapports de la IV conférence internationale. Paris, Masson, 1967;755-771.
32. British Tuberculosis Association. Chloroquine in the treatment of sarcoidosis: a report of the research committee of the British Tuberculosis Association. Tubercle 1967;48:257-272.
33. Brodthagen H, Gilg I. Hydroxychloroquine in the treatment of sarcoidosis. In: Turiaf J, Chabot J, eds. La sarcoïdose: rapports de la IV conférence internationale. Paris, Masson, 1967;764-767.
34. Johns CJ, Schonfeld SA, Scott PP, Zachary JB, Mac Gregor MI. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy: outcome and complications. Ann N Y Acad Sci 1986;465:702-712.
35. Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol 1990;23:487-489.
36. Desimone DP, Brilliant HL, Basile J, Bell NH. Granulomatous infiltration of the talus and abormal vitamine D and calcium metabolism in a patient with sarcoidosis: a successful treatment with hydroxychloroquine. Am J Med 1989;87:694-696.
37. Hughes JR, Pembroke AC. Cutaneous sarcoid treated with mepacrine. Clin Exp Dermatol 1994;19:448.
38. Segal R, Yaron M, Tartakovsky B. Methotrexate: mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum 1990;20:190-199.
39. Morgan SL, Baggot JE, Vaughn WH, Austin JS, Veitch TA, Lee JY, Koopman WJ, Krumdieck CL, Alarcon GS. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med 1994;121:833-841.
40. Veien NK, Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol 1977;97:213-216.
41. Henderson CA, Ilchyshyn A, Curry AR. Laryngeal and cutaneous sarcoidosis treated with methotrexate. J R Soc Med 1994;87:632-633.
42. Suda T, Sato A, Toyoshima M, Imokawa S, Yoshitomi A, Tamura R, Suganuma H, Yagi T, Hayakawa H, Shirai M. Weekly low-dose methotrexate therapy for sarcoidosis. Intern Med 1994;33:437-440.
43. Morin G, De Wazieres B, Humbert P, Dupond JL. Intérêt du methotrexate dans un cas de sarcoïdose cutanée floride. Ann Dermatol Vénéréol 1993;120:143-146.
44. Webster GF, Razsi LK, Sanchez M, Shupack JL. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991;24-451-454.
45. Lower EE, Baugham RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990;209:153-157.
46. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995;155:846-851.
47. Casavilla FA, Gordon R, Wright HI, Gavaler JS, Starzl TE, Van Thiel DH. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 1993;118:865-866.
48. Gupta AK, Ellis CN, Nickoloff BJ, Goldfarb MT, Ho VC, Rocher LL, Griffiths CEM, Cooper KD, Voorhees JJ. Oral cyclosporine in the treatment of inflammatory and non inflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol 1990:126:339-350.
49. Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM, Hosenpud JD. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992;11:367-369.
50. Bain VG, Kneteman N, Brown NE. Sarcoidosis, liver transplantation, and cyelosporine. Ann Intern Med 1993;119:1148.
51. O'Callaghan CA, Wells AU, Lalvani A, Dhillon PD, Hansell DM, Mitchell DN. Effective use of cyclosporine in sarcoidosis: a treatment strategy based on computed tomography scanning. Eur Respir J 1994;7:2255-2256.
52. Bileory L, Frohman LP. Low-dose cyclosporine therapy of granulomatous optic neuropathy and orbitopathy. Ophtalmology 1991;98:1732-1736.
53. Wakefield D, Maccluskey P. Cyclosporine: a therapy in inflammatory eye disease. J Ocul Pharmacol 1991;7:221-226.
54. York EL. Kovithavongs T, Man SF, Rebuck AS, Sproule BJ. Cyclosporine and chronic sarcoidosis. Chest 1990;98:1026-1029.
55. Levine SM, Anzueto A, Peters JI, Calhoon JH, Jenkinson SG, Bryan CL. Single lung transplantation in patients with systemic disease. Chest 1994;105:837-841.
56. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992;49:1065-1072.
57. Israel HL, McComb BL. Chlorambucil treatment of sarcoidosis. Sarcoidosis 1991;8:35-41.
58. Aghogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995;52:875-879.
59. Zuher M, Defer G, Cesaro P, Degos JD. Efficacy of cyclophosphamide in sarcoid radiculomyelitis. J Neurol Neurosurg Psychiatry 1992;55:166-167.
60. Waldinger TP, Ellis C, Quint K, Voorhees JJ. Treatment of cutaneous sarcoidosis with isotretinoin. Arch Dermatol 1983;119:1003-1005.
61. Vaillant L, Le Marchand D, Bertrand S, Grangeponte MC, Lorette G. Sarcoïdose cutanée annulaire du front: traitement par isotrétinoine. Ann Dermatol Vénéréol 1986;113:1089-1092.
62. Rosof BM. Allopurinol for sarcoid. N Eng J Med 1976;294:447.
63. Pollock JL. Sarcoidosis responding to allopurinol. Arch Dermatol 1980;116:273-274.
64. Barriere H. Sarcoïdes cutanées. Traitement par la thalidomide. Press Med 1983;12:963.
65. Carlesimo M, Giustini S, Rossi A, Bonaccorsi P, Calvieri S. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995;32:866-869.
66. Yamada H, Ide A, Sugiura M, Tajima S. Treatment of cutaneous sarcoidosis with tranilast. J Dermatol 1995;22:149-152.
67. Kaluza CL. Use of trimethoprim and sulfamethoxazole in the treatment of nasal sarcoidosis. Ear Nose Throat J 1991;70:52.
68. Samtsov AV. A comparative evaluation of the efficacity of different therapeutic methods in sareoidosis of the skin. Vestn Dermatol Venereol 1990;52-54.
69. Romanov VV, Khomenko IS, Ozerova LV, Gergert VI. Use of T-activin in patients with sarcoidosis. Probl Tuherk 1990;15-17.
70. Moretti AM, Colizzi M, Moretti B, Martucci G, Anlonaci S. Clinical and immunological findings in joint sarcoidosis in patients treated with thymopentin: a pilot study. International Journal of Immunotherapy 1990;6:231-237.
71. Courtois JM, Husson C, Dalac S, Chapelon M, Lambert D. Sarcoïdose cutanée et articulaire. Amélioration par la PUVAthérapie. Press Med 1987;16:1334-1335.
72. Goodman MM, Alpern K. Treatment of lupus pernio with the flashlamp pulsed dye laser. Lasers in surgery and medicine, 1992;12:549-551.
73. Cagnoni ML, Lombardi A, Cerinic MM, Dedola GL, Pignone A. Melatonin for treatment of chronic refractory sarcoidosis. Lancet 1995;346:1229-1230.
74. Philipp EE. Sarcoidosis; Pregnancy. Lung Biology in health and disease 1994;73:397-400.
75. Clark SK. Sarcoidosis in children. Pediatr Dermatol 1987;4:291-299.
76. Kamoun MR, Fazza B, Zeglaoui F, Mokhtar I, Bejaoui M. Sarcoïdose multiviscérale à révélation cutanée chez l'enfant. Ann. Dermatol. Venereol. 1994;121:190-93.
77. Geddes DM. Sarcoidosis: When and how should we treat ? Br J Hosp Med 1995;53:415.